Medicine and Dentistry
Programmed Death-Ligand 1
55%
Neoplasm
49%
Host
38%
Immunotherapy
37%
Nodular Melanoma
34%
Programmed Death 1 Ligand 1
33%
Therapeutic Procedure
27%
Female
22%
Autophagy
21%
Antibody
20%
CTLA-4
20%
Age
20%
Combination Therapy
19%
Tumor Cell
18%
Melanoma B16
16%
Immunity
16%
Cancer Stem Cell
16%
Malignant Neoplasm
12%
Cells
12%
Cancer Immunotherapy
11%
T Cell
11%
2 Chloro 5 Nitrobenzanilide
11%
Male
11%
Cancer Types
11%
Tumor Progression
11%
Ovarian Cancer
9%
Adipocyte
8%
Receptor
8%
Regulatory T Cell
8%
Breast Cancer
8%
Depletion
8%
Adipose Tissue
8%
Blocking Antibody
8%
Breast Tumor
8%
In Vitro
6%
Biological Marker
6%
Patient
5%
Peroxisome Proliferator Activated Receptor
5%
Sex Hormone
5%
Growth
5%
Glucose Metabolism
5%
Diet-Induced Obese
5%
Phenotype
5%
Sarcoma
5%
Castration
5%
Gender
5%
Obesity
5%
Proteus Syndrome
5%
Signaling Molecule
5%
Cooperation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Programmed Death-Ligand 1
100%
Neoplasm
45%
Host
38%
Immunotherapy
36%
Melanoma
33%
Programmed Death 1 Ligand 1
33%
Mouse
26%
Cytotoxic T Lymphocyte Antigen 4
20%
Antibody
19%
Melanoma B16
16%
Combination Therapy
16%
Tumor Growth
14%
Malignant Neoplasm
12%
Breast Cancer
10%
Breast Tumor
10%
Ovary Cancer
8%
Blocking Antibody
8%
Receptor
8%
Phosphotyrosine
7%
Sarcoma
5%
Obesity
5%
Biological Marker
5%
Sex Hormone
5%
Peroxisome Proliferator Activated Receptor
5%
Multiple Cancer
5%
Immunology and Microbiology
Host
38%
Immunotherapy
36%
Programmed Death 1 Ligand 1
33%
Mouse
26%
Cells
20%
CTLA-4
20%
Age
20%
Growth
20%
Monospecific Antibody
19%
Immune Checkpoint Blockade
19%
Immunity
18%
Autophagy
16%
Immunity
16%
Tumor Cell
15%
Breast
13%
Cancer Immunotherapy
11%
Blocking Antibody
8%
Regulatory T Cell
8%
Adipocyte
8%
Cytotoxic T-Cell
5%
Molecule
5%
Glucose Metabolism
5%
Gender
5%
Adipose Tissue
5%
Electric Potential
5%
Phenotype
5%
